Clinical trials
Completed Phase 1 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
195 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 6 |
| 2012 | 9 |
| 2013 | 16 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 13 |
| 2017 | 18 |
| 2018 | 20 |
| 2019 | 12 |
| 2020 | 15 |
| 2021 | 9 |
| 2022 | 14 |
| 2023 | 12 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 195 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biocad | 15 |
| Hoffmann-La Roche | 12 |
| Pharmtechnology LLC | 12 |
| AO GENERIUM | 10 |
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 10 |
| Novartis Pharmaceuticals | 8 |
| Boehringer Ingelheim | 7 |
| Viriom | 7 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 5 |
| Geropharm | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 9 |
| Neoplasms | 9 |
| Arthritis, Rheumatoid | 8 |
| Breast Neoplasms | 8 |
| Influenza, Human | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Immune System Diseases | 5 |
| Lymphoma, Follicular | 5 |
| Prostatic Neoplasms | 5 |
Trials
Showing 1 to 25 of 195. Each trial links to its page on Pharma Observatory.
95 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.